Logo
x

Search

Subscribe Now

lupus nephritis

Aurinia to Present Results of Lupkynis (voclosporin) in AURORA 2 Continuation Study for Lupus Nephritis at EULAR 2021

Aurinia to Present Results of Lupkynis (voclosporin) in AURORA 2 Continuation Study for Lupus Nephritis at EULAR 2021

  • May 21, 2021
GSK's Benlysta (belimumab) Receives CHMP's Opinion Recommending its Approval for Active Lupus Nephritis

GSK's Benlysta (belimumab) Receives CHMP's Opinion Recommending its Approval for Active Lupus Nephritis

  • March 29, 2021
Roche Reports Results of Gazyva (obinutuzumab) in P-II NOBILITY Study for Lupus Nephritis

Roche Reports Results of Gazyva (obinutuzumab) in P-II NOBILITY Study for Lupus Nephritis

  • November 11, 2019
Roche's Gazyva (obinutuzumab) Receives FDA's Breakthrough Therapy Designation for Lupus Nephritis

Roche's Gazyva (obinutuzumab) Receives FDA's Breakthrough Therapy Designation for Lupus Nephritis

  • September 18, 2019
ImmPACT Bio’ IMPT-514 Receives the US FDA’s Fast Track Designation for Refractory Lupus Nephritis and Systemic Lupus Erythematosus

    ImmPACT Bio’ IMPT-514 Receives the US FDA’s Fast Track Designation for Refractory Lupus Nephritis and Systemic Lupus Erythematosus

    • October 11, 2023
    Kezar Life Sciences Entered into a Collaboration and License Agreement with Everest Medicines for Zetomipzomib to Treat Lupus Nephritis

      Kezar Life Sciences Entered into a Collaboration and License Agreement with Everest Medicines for Zetomipzomib to Treat Lupus Neph...

      • September 22, 2023
      Aurinia Published P-III Extension Study (AURORA 2) Results of Lupkynis (voclosporin) for Lupus Nephritis in Arthritis & Rheumatology

        Aurinia Published P-III Extension Study (AURORA 2) Results of Lupkynis (voclosporin) for Lupus Nephritis in Arthritis & Rheumatolo...

        • July 20, 2023
        Biocad CJSC Reports Retrospective Cohort Analysis of BCD-020 (biosimilar, rituximab) for Pediatric Patients with Lupus Nephritis

          Biocad CJSC Reports Retrospective Cohort Analysis of BCD-020 (biosimilar, rituximab) for Pediatric Patients with Lupus Nephritis

          • June 20, 2023
          Otsuka’s Lupkynis (voclosporin) Receives NICE Recommendation for the Treatment of Active Lupus Nephritis

            Otsuka’s Lupkynis (voclosporin) Receives NICE Recommendation for the Treatment of Active Lupus Nephritis

            • May 4, 2023
            Dr. Volker Knappertz, EVP R&D, Aurinia Shares Insights on LUPKYNIS MAA from EMA

              Dr. Volker Knappertz, EVP R&D, Aurinia Shares Insights on LUPKYNIS MAA from EMA

              • December 7, 2022
              Image

              Incisive News in 3 Shots.

              Contact Us

              Our Information

              Follow Us

              Copyright © 2025 PharmaShots - All Rights Reserved.